These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 33785249)

  • 81. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
    J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Transcription-based drug repurposing for COVID-19.
    Killick R; Ballard C; Doherty P; Williams G
    Virus Res; 2020 Dec; 290():198176. PubMed ID: 32987033
    [TBL] [Abstract][Full Text] [Related]  

  • 84. COVID-19 and Diabetes.
    Singh AK; Khunti K
    Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies.
    Longo M; Caruso P; Maiorino MI; Bellastella G; Giugliano D; Esposito K
    Cardiovasc Diabetol; 2020 Jul; 19(1):115. PubMed ID: 32698837
    [TBL] [Abstract][Full Text] [Related]  

  • 86. COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
    Lim S; Bae JH; Kwon HS; Nauck MA
    Nat Rev Endocrinol; 2021 Jan; 17(1):11-30. PubMed ID: 33188364
    [TBL] [Abstract][Full Text] [Related]  

  • 87. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 88. Managing diabetes in diabetic patients with COVID: where do we start from?
    Avogaro A; Bonora B; Fadini GP
    Acta Diabetol; 2021 Nov; 58(11):1441-1450. PubMed ID: 34173070
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.
    Codo AC; Davanzo GG; Monteiro LB; de Souza GF; Muraro SP; Virgilio-da-Silva JV; Prodonoff JS; Carregari VC; de Biagi Junior CAO; Crunfli F; Jimenez Restrepo JL; Vendramini PH; Reis-de-Oliveira G; Bispo Dos Santos K; Toledo-Teixeira DA; Parise PL; Martini MC; Marques RE; Carmo HR; Borin A; Coimbra LD; Boldrini VO; Brunetti NS; Vieira AS; Mansour E; Ulaf RG; Bernardes AF; Nunes TA; Ribeiro LC; Palma AC; Agrela MV; Moretti ML; Sposito AC; Pereira FB; Velloso LA; Vinolo MAR; Damasio A; Proença-Módena JL; Carvalho RF; Mori MA; Martins-de-Souza D; Nakaya HI; Farias AS; Moraes-Vieira PM
    Cell Metab; 2020 Sep; 32(3):437-446.e5. PubMed ID: 32697943
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Continuing or stopping metformin in patients with type 2 diabetes exposed to SARS-CoV-2 ?].
    Scheen AJ; Paquot N
    Rev Med Liege; 2021 Mar; 76(3):152-155. PubMed ID: 33682382
    [TBL] [Abstract][Full Text] [Related]  

  • 92. COVID-19, Hyperglycemia, and New-Onset Diabetes.
    Khunti K; Del Prato S; Mathieu C; Kahn SE; Gabbay RA; Buse JB
    Diabetes Care; 2021 Dec; 44(12):2645-2655. PubMed ID: 34625431
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.
    Sun H; Du Y; Kumar R; Buchkovich N; He P
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1176-H1193. PubMed ID: 36269646
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications.
    Higashikuni Y; Liu W; Obana T; Sata M
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769508
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.
    Nägele MP; Haubner B; Tanner FC; Ruschitzka F; Flammer AJ
    Atherosclerosis; 2020 Dec; 314():58-62. PubMed ID: 33161318
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Is DPP4 inhibition a comrade or adversary in COVID-19 infection.
    Dalan R
    Diabetes Res Clin Pract; 2020 Jun; 164():108216. PubMed ID: 32416120
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.
    Zhu B; Wei X; Narasimhan H; Qian W; Zhang R; Cheon IS; Wu Y; Li C; Jones RG; Kaplan MH; Vassallo RA; Braciale TJ; Somerville L; Colca JR; Pandey A; Jackson PEH; Mann BJ; Krawczyk CM; Sturek JM; Sun J
    Sci Immunol; 2023 Apr; 8(82):eadf0348. PubMed ID: 36821695
    [TBL] [Abstract][Full Text] [Related]  

  • 99. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.
    Sharma P; Behl T; Sharma N; Singh S; Grewal AS; Albarrati A; Albratty M; Meraya AM; Bungau S
    Biomed Pharmacother; 2022 Jul; 151():113089. PubMed ID: 35569351
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Infections and diabetes: Risks and mitigation with reference to India.
    Unnikrishnan R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1889-1894. PubMed ID: 33002780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.